Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy-Reference-Cited by-同舟云学术

Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy

Published:2021-01 Issue:1 Volume:11 Page:156-180
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Chang Xiaosa,Sun Dejuan,Shi Danfeng,Wang Guan,Chen Yanmei,Zhang Kai,Tan Huidan,Liu Jie,Liu Bo,Ouyang Liang

Funder

Department of Science and Technology of Sichuan Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference72 articles.

1. Basal-like breast carcinomas: clinical outcome and response to chemotherapy;Banerjee;J Clin Pathol,2006

2. Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer;Chowdhury;Acta Pharm Sin B,2018

3. Therapeutic landscape in mutational triple negative breast cancer;Shi;Mol Canc,2018

4. Metastatic triple negative breast cancer: optimizing treatment options, new and emerging targeted therapies;Khosravi-Shahi;Asia Pac J Clin Oncol,2017

5. Second primary cancer after female breast cancer: familial risks and cause of death;Zheng;Cancer Med,2019

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, biological evaluation of novel piperidine-based derivatives as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors;Bioorganic Chemistry;2024-07

2. Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer;Medicinal Research Reviews;2024-05-20

3. Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines;Molecules;2024-03-21

4. Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8;European Journal of Medicinal Chemistry;2024-03

5. Design and synthesis of the first PARP-1 and proteasome dual inhibitors to treat breast cancer;European Journal of Medicinal Chemistry;2024-01